The phrase "aggregation dependent manner" is correct and usable in written English.
It can be used in contexts where the behavior or outcome is influenced by the aggregation of certain elements or data.
Example: "The results of the experiment varied significantly in an aggregation dependent manner, highlighting the importance of data collection methods."
Alternatives: "aggregation-based approach" or "manner dependent on aggregation".
Once aggregation-enabled, however, the N-terminal fragments can impair the neurite growth in an aggregation-dependent manner.
P19 cells are pluripotent embryonal carcinoma (EC) cells, derived from mouse embryonic stem (ES) cells, that can differentiate into cardiac and skeletal muscle in a dimethylsulfoxide (DMSO)- and aggregation-dependent manner [ 13].
However, it has been shown to inhibit CaOx crystal aggregation in concentration dependent manner [ 194].
PrTX-III induced a platelet aggregation in a dose dependent manner and this effect was abolished by previous treatment with HP-2.
Increasing amounts of Ficoll and dextran enhanced aggregation in a concentration dependent manner (4-fold and higher at 200 g/L).
Recently, an in vitro study conducted in rabbit platelets showed that EPA, DPA and DHA inhibited collagen- or arachidonic acid stimulated platelet aggregation in a dose dependent manner, with DPA being the most potent inhibitor and possibly ten times more powerful than EPA in inhibiting platelet aggregation.
rBPI21 promotes the aggregation of LPS aggregates in a concentration dependent manner (Figures 1 and 2).
While fibril morphology did not appear to be significantly altered when mutants were prepped similarly and incubated under free solution conditions, aggregation in the lipid membranes resulted in a variety of polymorphic aggregates in a mutation dependent manner.
We found that LX0702 inhibited platelet aggregation induced by ADP, thrombin and collagen in a dose dependent manner, with IC50 values of 49.90 ± 2.03, 50.65 ± 0.34 and 83.90 ± 2.06 μM, respectively.
Furthermore, SRH inhibited the ADP-induced platelet aggregation in dose-dependent manner while SAK had no significant effect on platelet aggregation.
A β aggregation and clearance are differently affected in an isoform (ε2, ε3, and ε4) dependent manner; frequency of AD and mean age at clinical onset are 91% and 68 years of age in ε4 homozygote, 47% and 76 years of age in ε4 heterozygote, and 20% and 84 years in ε4 noncarriers [ 172, 174].
